Alcyomics

Knowledge Source Identification
Knowledge source name Alcyomics
Owner/Developer Alcyomics Ltd
Country United Kingdom
Languages English
URL http://www.alcyomics.com/index.html
Contact email anne.m.dickinson@alcyomics.com
Description Alcyomics offers human in vitro (lab-based) pre-clinical safety testing to ensure drug safety and efficacy before first administration into man. We offer a consultancy service of how the pre-clinical data can be used to assist clinical trial development such as dose response and a stratified medicine approach to patient selection. Our technology is also a suitable alternative to animal testing for the cosmetics industry. In addition we offer immunogenicity and potency testing of novel chemicals. Alcyomics was founded in 2007 and started trading in 2009, providing technology support to the biotechnology, pharmaceutical and cosmetic industries, building on 30 years' research experience with the use of skin explant assays for predicting graft versus host disease and understanding its immunobiology.
Knowledge Source Category
Category Organization
Sub categories Contract Research Organization, R&D Company
Knowledge Dissemination and Sharing
Dissemination channel Website, Social media, Professional online network
Targeted audience (specified/objective analysis) Industry
Users access Open access
Knowledge Characterization
3Rs relevance Replacement
Purpose Method development, Toxicological and safety evaluation, Efficacy testing
Technology/Tools Alternative test methods (in vitro)